These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19693090

  • 1. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM.
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [Abstract] [Full Text] [Related]

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 3. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
    Shastry A, Sedimbi SK, Rajalingam R, Rumba I, Kanungo A, Sanjeevi CB.
    Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
    [Abstract] [Full Text] [Related]

  • 4. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [Abstract] [Full Text] [Related]

  • 5. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E, International Histocompatibility Working Group.
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
    [Abstract] [Full Text] [Related]

  • 6. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [Abstract] [Full Text] [Related]

  • 7. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
    Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT.
    Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
    [Abstract] [Full Text] [Related]

  • 8. [Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].
    Jiang LX, Xu LH, Qi CP, Wang YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):863-5. PubMed ID: 22863597
    [Abstract] [Full Text] [Related]

  • 9. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F, Tajik N, Entezami KZ, Fallah Radjabzadeh M, Asadifar B, Alimoghaddam K, Ostadali Dahaghi M, Jalali A, Ghashghaie A, Ghavamzadeh A.
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [Abstract] [Full Text] [Related]

  • 10. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R.
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [Abstract] [Full Text] [Related]

  • 11. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A.
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [Abstract] [Full Text] [Related]

  • 12. Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages.
    Faridi RM, Agrawal S.
    Hum Reprod; 2011 Feb; 26(2):491-7. PubMed ID: 21159685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ, Brooks AG, Stewart LA, Nguyen TH, Schwarer AP.
    J Immunol; 2009 Oct 01; 183(7):4502-8. PubMed ID: 19748981
    [Abstract] [Full Text] [Related]

  • 15. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R, Chessa L, Onali S, Figorilli F, Lai S, Secci L, La Nasa G, Caocci G, Arras M, Melis M, Cappellini S, Balestrieri C, Serra G, Conti M, Zolfino T, Casale M, Casu S, Pasetto MC, Barca L, Salustro C, Matta L, Scioscia R, Zamboni F, Faa G, Orrù S, Carcassi C.
    PLoS One; 2016 Oct 01; 11(1):e0146086. PubMed ID: 26744892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y.
    Clin Immunol; 2010 Oct 01; 137(1):139-46. PubMed ID: 20643584
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.
    Tissue Antigens; 2012 Feb 01; 79(2):90-6. PubMed ID: 22128749
    [Abstract] [Full Text] [Related]

  • 20. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF.
    Ann Neurol; 2009 Jun 01; 65(6):658-66. PubMed ID: 19630074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.